Ads
related to: moderna vaccine
Search results
Moderna: FDA Extends RSV Vaccine Review, But No Issues Flagged
Morningstar· 5 days agoThe company said the FDA cited administrative constraints for the delay, and that the agency is working to complete its review of mRNA-1345 by the end of the month. Moderna
Moderna Tumbles After The FDA Throws A Curveball On Its Second Product
Investor's Business Daily· 4 days ago"Although regulatory delays are disappointing and usually create noise around the probability of...
Moderna Says FDA Delaying Decision on RSV Vaccine Approval
Bloomberg· 5 days agoHave a confidential tip for our reporters? US regulators’ decision on whether to approve Moderna...
Moderna and OpenAI Are Teaming Up, but Does That Make the Stock a Buy?
Motley Fool via Yahoo Finance· 3 days agoIf the lofty claims made by others in the biotech industry are true, the company could see a...
Novavax stock skyrockets 120% on $1.2 billion vaccine deal with Sanofi
Quartz· 5 days agoVaccine-maker Novavax announced a $1.2 billion licensing partnership with French pharmaceutical...
What's Going With Moderna Stock On Friday? - Moderna (NASDAQ:MRNA)
Benzinga· 5 days agoThe agency, citing administrative constraints, does not expect to complete its review of the Biologics License Application (BLA) for mRNA-1345, Moderna’s investigational respiratory ...
Moderna says FDA delaying decision on RSV vaccine approval, shares fall
Investing.com· 5 days agoModerna says FDA delaying decision on RSV vaccine approval, shares fall
Moderna’s mRNA dreams meet reality with first post-COVID shot - The Boston Globe
The Boston Globe· 5 days agoModerna’s stock dropped 45 percent last year, making it the worst-performing large biotech in the...
Moderna says FDA delaying decision on RSV vaccine approval
Stars and Stripes· 5 days agoUS regulators’ decision on whether to approve Moderna Inc.’s vaccine for RSV has been delayed due to...
Bull Market and Beyond: 2 Stocks Just Waiting to Soar | The Motley Fool
The Motley Fool· 2 days agoLet's consider two such stocks: Moderna (MRNA 7.13%) and DexCom (DXCM -1.65%). Moderna is one of the...